Scientific views


Dec, 2020

Pablo Rojo & Anna Turkova comment on HIV drug optimisation for adolescents living with HIV


Pablo Rojo, and Anna Turkova – members of Penta ID network have provided some rationale, and highlighted some challenges related to including adolescents in HIV clinical phase 3 trials of antiretroviral drugs in their co-authored commentary titled, “The HIV drug optimisation agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV” in the Journal of the International AIDS Society.


We would like to update you on our recent activities